ASP Isotopes (NASDAQ:ASPI) Shares Gap Up – Here’s What Happened

ASP Isotopes Inc. (NASDAQ:ASPI) gapped up prior to trading on Tuesday . The stock had previously closed at $5.55, but opened at $6.38. ASP Isotopes shares last traded at $6.91, with a volume of 4,227,527 shares traded.

Wall Street Analyst Weigh In

ASPI has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Canaccord Genuity Group restated a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, ASP Isotopes presently has an average rating of “Hold” and a consensus target price of $13.00.

ASP Isotopes Stock Up 22.0%

The stock has a market cap of $852.34 million, a price-to-earnings ratio of -3.25 and a beta of 3.26. The business has a fifty day moving average of $5.06 and a 200 day moving average of $5.91. The company has a debt-to-equity ratio of 0.69, a current ratio of 4.39 and a quick ratio of 12.20.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, May 20th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.28) by $0.06. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%. The company had revenue of $8.36 million during the quarter, compared to the consensus estimate of $3.68 million.

Insider Buying and Selling at ASP Isotopes

In other news, Director Duncan Moore sold 11,642 shares of the company’s stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of $5.21, for a total transaction of $60,654.82. Following the completion of the sale, the director owned 1,044,928 shares in the company, valued at approximately $5,444,074.88. This represents a 1.10% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Robert Ainscow sold 25,000 shares of the company’s stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $4.51, for a total value of $112,750.00. Following the sale, the chief operating officer owned 1,512,817 shares of the company’s stock, valued at approximately $6,822,804.67. This trade represents a 1.63% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 90,704 shares of company stock worth $463,252 over the last three months. Corporate insiders own 14.40% of the company’s stock.

Institutional Trading of ASP Isotopes

Several large investors have recently made changes to their positions in ASPI. State of Wyoming bought a new stake in shares of ASP Isotopes during the 1st quarter worth about $29,000. Quantbot Technologies LP bought a new stake in shares of ASP Isotopes during the 3rd quarter worth about $34,000. BNP Paribas Financial Markets boosted its stake in shares of ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after acquiring an additional 2,548 shares in the last quarter. Stephens Inc. AR bought a new stake in shares of ASP Isotopes during the 1st quarter worth about $44,000. Finally, Broadhurst Jeffrey B bought a new stake in shares of ASP Isotopes during the 1st quarter worth about $44,000. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.